{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Injectable+Placebo&page=100", "query": { "intervention": "Injectable Placebo", "page": 100 }, "page_size": 10 }, "pagination": { "page": 100, "page_size": 10, "total_count": 4226, "total_pages": 423, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Injectable+Placebo&page=101&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Injectable+Placebo&page=99&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T01:16:53.061Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01514149", "title": "Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus (T2DM)" ], "interventions": [ { "name": "CJC-1134-PC Injection", "type": "DRUG" }, { "name": "Weekly placebo for CJC-1134-PC Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ConjuChem", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 73, "start_date": "2011-09", "completion_date": "2013-03", "has_results": true, "last_update_posted_date": "2017-07-19", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Inglewood, California • Tarzana, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Inglewood", "state": "California" }, { "city": "Tarzana", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Wellington", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01514149" }, { "nct_id": "NCT01690299", "title": "Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis", "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast", "type": "DRUG" }, { "name": "Etanercept", "type": "DRUG" }, { "name": "Placebo tablet", "type": "DRUG" }, { "name": "Placebo injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2012-10-01", "completion_date": "2016-04-04", "has_results": true, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Bakersfield, California • Irvine, California + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01690299" }, { "nct_id": "NCT00580216", "title": "Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "Idrabiotaparinux sodium", "type": "DRUG" }, { "name": "Warfarin", "type": "DRUG" }, { "name": "Placebo (for idrabiotaparinux)", "type": "DRUG" }, { "name": "Placebo (for warfarin)", "type": "DRUG" }, { "name": "Avidin", "type": "DRUG" }, { "name": "Placebo (for avidin)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3773, "start_date": "2007-12", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2016-03-21", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 162, "location_summary": "Mobile, Alabama • Tucson, Arizona • Little Rock, Arkansas + 134 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Mountain Home", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00580216" }, { "nct_id": "NCT04120116", "title": "FX-322 in Adults With Stable Sensorineural Hearing Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sensorineural Hearing Loss", "Noise Induced Hearing Loss", "Sudden Sensorineural Hearing Loss" ], "interventions": [ { "name": "FX-322 (One Dose)", "type": "DRUG" }, { "name": "FX-322 (Two Doses)", "type": "DRUG" }, { "name": "FX-322 (Four Doses)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Frequency Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 95, "start_date": "2019-10-04", "completion_date": "2020-12-17", "has_results": true, "last_update_posted_date": "2023-04-27", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 16, "location_summary": "Fresno, California • Torrance, California • Colorado Springs, Colorado + 12 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04120116" }, { "nct_id": "NCT00818948", "title": "Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Nephritis", "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "AMG 811", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 56, "start_date": "2009-03", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2014-09-15", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 8, "location_summary": "Phoenix, Arizona • Danbury, Connecticut • Kansas City, Kansas + 5 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Danbury", "state": "Connecticut" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Manhasset", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00818948" }, { "nct_id": "NCT06565195", "title": "A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "LY3962681", "type": "DRUG" }, { "name": "Placebo (aCSF)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Prevail Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "30 Years to 80 Years" }, "enrollment_count": 124, "start_date": "2024-08-27", "completion_date": "2030-07-23", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 7, "location_summary": "Englewood, Colorado • New Haven, Connecticut • Naples, Florida + 4 more", "locations": [ { "city": "Englewood", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Naples", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Farmington Hills", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06565195" }, { "nct_id": "NCT05794581", "title": "A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "CT-868", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Victoza", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Carmot Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 32, "start_date": "2023-03-21", "completion_date": "2024-04-06", "has_results": false, "last_update_posted_date": "2024-12-27", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05794581" }, { "nct_id": "NCT00662519", "title": "Neulasta in Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Neulasta (Pegylated)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Mixed Meal Tolerance Test (MMTT)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Blood test", "type": "OTHER" }, { "name": "DNA Test", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 21, "start_date": "2008-04", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2015-04-09", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00662519" }, { "nct_id": "NCT02057172", "title": "Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "HM11260C", "type": "DRUG" }, { "name": "liraglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hanmi Pharmaceutical Company Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 254, "start_date": "2014-01", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2016-08-09", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 1, "location_summary": "CA, California", "locations": [ { "city": "CA", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02057172" }, { "nct_id": "NCT02918019", "title": "A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "MSTT1041A", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 517, "start_date": "2016-09-20", "completion_date": "2019-07-26", "has_results": true, "last_update_posted_date": "2022-12-28", "last_synced_at": "2026-11-10T01:16:53.061Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Bakersfield, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02918019" } ] }